LD-2 disclosure · 2nd Quarter - Report

DRUG POLICY ACTION

2nd Quarter (Apr 1 - June 30) · 2022Posted Sept 10, 2022Filing document ↗LDA record ↗

Income$40Kfee reported

Client

Name: DRUG POLICY ACTION
Description: Drug Policy Action works to pass drug laws grounded in science, health, and human rights.
Location: New York · United States of America

Firm: COLLIER COLLECTIVE, LLC
Description: A firm that specializes in policy advocacy and strategy for public interest clients.
Location: Washington, District of Columbia, United States of America

3 issues

Budget/Appropriations
1. Advocated for increased FY23 funding in the Labor, Health & Human Services, Education, and Related Agencies appropriations bill for HHS/CDC's Infectious Diseases & Opioid Epidemic program to expand access to overdose prevention and other harm reduction services to help prevent skyrocketing overdose deaths nationwide and prevent the transmission of infectious diseases. 2. Advocated on implementation of $30 million in American Rescue Plan Act funding to support overdose prevention, syringe services programs, and harm reduction services authorized and allocated by the American Rescue Plan Act.
LobbyistsJENNY COLLIER · DANIELLE NEAL
TargetedSENATE · HOUSE OF REPRESENTATIVES · Office of Natl Drug Control Policy (NDCP) · Substance Abuse & Mental Health Services Administration (SAMHSA)
Law Enforcement/Crime/Criminal Justice
Advocated on the effectiveness of overdose prevention centers and the need for the Administration to permit and support this intervention in the U.S. to help save lives by reducing drug overdose deaths.
LobbyistsJENNY COLLIER
TargetedOffice of Natl Drug Control Policy (NDCP) · Justice, Dept of (DOJ)
Health Issues
Advocated for not including or limiting the ban on the use of federal funds to purchase safe supplies for the use of drugs to reduce the transmission of infectious diseases and reduce drug overdoses in H.R. HR 7666, "The Restoring Hope for Mental Health and Well-Being Act of 2022."

LD-2 disclosure · 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) · 2022Posted Sept 10, 2022Filing document ↗LDA record ↗

Income$40Kfee reported

Name: DRUG POLICY ACTION
Description: Drug Policy Action works to pass drug laws grounded in science, health, and human rights.
Location: New York · United States of America

Firm: COLLIER COLLECTIVE, LLC
Description: A firm that specializes in policy advocacy and strategy for public interest clients.
Location: Washington, District of Columbia, United States of America

3 issues

Budget/Appropriations
1. Advocated for increased FY23 funding in the Labor, Health & Human Services, Education, and Related Agencies appropriations bill for HHS/CDC's Infectious Diseases & Opioid Epidemic program to expand access to overdose prevention and other harm reduction services to help prevent skyrocketing overdose deaths nationwide and prevent the transmission of infectious diseases. 2. Advocated on implementation of $30 million in American Rescue Plan Act funding to support overdose prevention, syringe services programs, and harm reduction services authorized and allocated by the American Rescue Plan Act.
LobbyistsJENNY COLLIER · DANIELLE NEAL
TargetedSENATE · HOUSE OF REPRESENTATIVES · Office of Natl Drug Control Policy (NDCP) · Substance Abuse & Mental Health Services Administration (SAMHSA)
Law Enforcement/Crime/Criminal Justice
Advocated on the effectiveness of overdose prevention centers and the need for the Administration to permit and support this intervention in the U.S. to help save lives by reducing drug overdose deaths.
LobbyistsJENNY COLLIER
TargetedOffice of Natl Drug Control Policy (NDCP) · Justice, Dept of (DOJ)
Health Issues
Advocated for not including or limiting the ban on the use of federal funds to purchase safe supplies for the use of drugs to reduce the transmission of infectious diseases and reduce drug overdoses in H.R. HR 7666, "The Restoring Hope for Mental Health and Well-Being Act of 2022."